MURAL ONCOLOGY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.23 USD | -2.12% |
|
-3.58% | -45.44% |
| 04/04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
| 08/01 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
Evolution of the average Target Price on Mural Oncology plc
Price target over the last 5 years
History of analyst recommendation changes
8c5d694012c86c554c8ed0b77a.uQXVyj4CsQwT_FfyAw9BFxPJINawXjZw_eON5Em9qS4.0GGgn21JiUtishrENGlyR2n7b7SHD18fv5POvCWLyBnOQoKaSGnpZUC2Fg~b3abf037e58b411888972d52851b4f38
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.23
USD
Average target price
13
USD
Spread / Average Target
+302.48%
High Price Target
13
USD
Spread / Highest target
+302.48%
Low Price Target
13
USD
Spread / Lowest Target
+302.48%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Mural Oncology plc
| Morgan Stanley |
Chiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- MURA Stock
- Consensus Mural Oncology plc
